Day: March 9, 2021

Innofactor Oyj:n Tilinpäätös ja toimintakertomus 9.3.2021 klo 8.00Innofactorin vuoden 2020 suomenkielinen vuosikertomus on julkaistu PDF-muodossa yhtiön internet-sivuilla: www.innofactor.com/fi/sijoittajille/tiedotteet-julkaisut-ja-selvitykset/#vuosikertomukset. Vuosikertomus sisältää tilinpäätöksen ja hallituksen toimintakertomuksen.Yhtiön selvitys hallinto- ja ohjausjärjestelmästä tilikaudelta 2020 on julkaistu toimintakertomuksesta erillisenä yhtiön internet-sivuilla: https://www.innofactor.com/fi/sijoittajille/hallinto-ja-johtaminen/.Palkitsemisraportti tilikaudelta 2020 on julkaistu yhtiön internet-sivulla: www.innofactor.com/fi/sijoittajille/hallinto-ja-johtaminen/#palkitseminen.Vuosikertomuksen englanninkielinen käännös on saatavilla arviolta huhti-toukokuun vaihteessa.Painetun vuosikertomuksen voi tilata osoitteesta: ir@innofactor.com.Espoossa...

Innofactor Plc Annual Financial Report, on March 9, 2021, at 8:00 Finnish timeInnofactor Annual Report for 2020 has been published in Finnish as a PDF file on the company’s web site: www.innofactor.com/invest-in-us/releases-publications-and-reports/#annual-reports. The Annual Report includes the Financial Statement and the Report of the Board of Directors.Innofactor’s Corporate Governance Statement for the Financial Period 2020 has been published separately from the Annual Report on the company’s web site: https://www.innofactor.com/invest-in-us/corporate-governance/.The Remuneration Report for the Financial Period 2020 has been published on the company’s web site: www.innofactor.com/invest-in-us/corporate-governance/#compensations.The English version of the Annual Report is estimated to be available during April–May...

ROTTERDAM, The Netherlands (9 March 2021) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that it has reached an agreement to sell its Nutri Granulations manufacturing asset and associated business to Huber Engineered Materials (“HEM”), a division of J.M. Huber Corporation (“Huber”).“Huber is an important supplier partner for IMCD and we are delighted to reach an agreement on the sale of Nutri Granulations,” says Marcus Jordan, Americas President, IMCD. “HEM is a favorable long-term fit for Nutri Granulations and this agreement aligns with IMCD’s strategy to focus on the sales, marketing, and distribution of speciality chemicals and ingredients.”Located in La Mirada, CA, with 22 employees, Nutri Granulations manufactures food grade and USP grade calcium carbonate granulations...

In 2020 Inbank earned a net profit of 5.9 million euros, which is 41% less than the previous year. Inbank’s loan portfolio increased by 19% compared to 2019 reaching 402 million euros. At the same time, the deposit portfolio grew 4%, reaching 391 million euros at year-end. The annual return on equity was 10.8%.Annual sales volume in 2020 was 300 million euros; that is, a 4% increase year-on-year. In all markets, the sales finance business grew by 38% to 206 million euros. At the same time, the sales volume of personal loans decreased by 51% to 36 million euros, while car financing decreased in sales volume by 11% to 58 million euros.Provisions for loan losses increased by 91% year-on-year to 11.5 million euros.By the end of 2020, the number of active contracts reached 690,000 growing 25% year-on-year. The number of active partners grew...

Inbanki 2020. aasta puhaskasum oli 5,9 miljonit eurot, mis on 41% vähem kui eelmisel aastal. Laenuportfell kasvas 2019. aastaga võrreldes 19% ja ulatus 402 miljoni euroni. Hoiuseportfell kasvas 4% ja ulatus aasta lõpu seisuga 391 miljoni euroni. Aastane omakapitali tootlus oli 10,8%.Kokku müüs Inbank 2020. aastal krediiditooteid 300 miljoni euro eest, mis on 4% rohkem kui 2019. aastal. Kõikidel turgudel kokku kasvas järelmaksu äri 38% ja ulatus 206 miljoni euroni. Väikelaenu müügimaht kahanes samal ajal 51% ja oli 36 miljonit eurot, autode finantseerimise müügimaht vähenes 11% ja oli 58 miljonit eurot.Eraldised laenukahjumite katteks kasvasid eelmise aastaga võrreldes 91% ja olid 11,5 miljonit eurot.Aasta lõpus oli Inbankil 690 000 aktiivset kliendilepingut, mis on eelmise aastaga võrreldes 25% enam. Partnerite arv kasvas aastaga 31%...

Geneva, Switzerland, March 9, 2021 – Addex Therapeutics (SIX:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will issue its full-year 2020 financial results on Thursday March 11, 2021.  Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology will provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and the media on Thursday, March 11, 2021 at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST).Title:                Addex to announce full-year 2020 financial resultsDate:               March 11, 2021Time:               16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST).Joining the Conference Call:1: In the 10 minutes prior to the call start time, call the appropriate participant...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.Pratteln, Switzerland, March 9, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that while a large majority of 89 % of bondholders represented at yesterday’s bondholders’ meeting voted in favor of the resolutions proposed by the Company, the required threshold of 2/3 of all bonds outstanding to pass such resolutions was not met. Bondholders may still cast their vote for the resolution that would enable a restructuring of the CHF 60 million 5% Convertible Bonds due 2022.A total principal amount of CHF 39,130,000 (65%) of the bonds was represented at the meeting and thereof CHF 34,775,000 or 89% voted in favor of the resolution. However, these votes in favor, representing 58% of the total bonds outstanding...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.Pratteln, Schweiz, 9. März 2021 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass an der gestrigen Anleihensgläubigerversammlung zwar eine grosse Mehrheit von 89% für die Beschlüsse gestimmt hat, jedoch der für eine Annahme erforderliche Schwellenwert von 2/3 aller ausstehenden Obligationen nicht erreicht wurde. Die Anleihensgläubiger können weiterhin ihre Stimme für den Beschluss abgeben, der eine Restrukturierung der 2022 fällig werdenden CHF 60 Millionen 5% Wandelanleihe ermöglichen würde.Insgesamt waren CHF 39’130’000 (65%) der Obligationen an der Anleihensgläubigerversammlung vertreten und davon stimmten CHF 34’775’000 oder 89% für den Beschluss. Diese Ja-Stimmen, die 58% der gesamten...